Trade Delcath Systems, Inc. - DCTH CFD

Trading Conditions

• Type: CFD
• Spread: 0.1
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 9.65
• Open: 9.59
• 1-Year Change: -12.58%
• Day's Range: 9.47 - 9.74

Trade Delcath Systems, Inc. - DCTH CFD

What is Delcath Systems, Inc. (DCTH)?

Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on the development and commercialization of innovative oncology therapies. The company specializes in targeted chemotherapy delivery systems designed to treat cancers with localized drug administration, aiming to improve therapeutic outcomes while minimizing systemic side effects. Its primary technology involves a proprietary catheter system that isolates the liver's blood supply to deliver high doses of chemotherapy directly to liver tumors. This approach is intended to enhance the concentration of chemotherapeutic agents at the tumor site while reducing exposure to the rest of the body. Delcath Systems operates within the broader field of interventional oncology, contributing to minimally invasive treatment options for patients with hepatic malignancies. The company's efforts include clinical research, regulatory activities, and collaboration with healthcare providers to advance its therapeutic platforms. Delcath Systems is headquartered in the United States and engages in ongoing development to expand the applications of its technology in cancer treatment.

Delcath Systems, Inc. Stock Price Today: Live Overview

The price today is shaped by current market movements as Delcath Systems, Inc. trades at $9.71. Intraday, the price ranged from $9.47 to $9.75, showing a variation of -0.4141%.

FAQ: Delcath Systems, Inc. (DCTH)

What is the current price of DCTH stock?

The current price is $9.71.

Does DCTH pay dividends?

Delcath Systems, Inc. does not currently pay dividends.

Does DCTH have a formal corporate presence or regional headquarters in the UAE?

Delcath Systems, Inc. operates in the UAE through partners and distributors without an official office or subsidiary.

What is DCTH best known for?

Delcath Systems, Inc. is most famous for its cancer treatment systems using targeted chemotherapy.

What assets are typically shown together with DCTH?

Commonly shown alongside DCTH: Centessa Pharmaceuticals Limited, Opendoor Technologies Inc, ANGI Homeservices